Moran Wealth Management, LLC

Position in EXEL — Exelixis, Inc.

CIK 1965334 Naples, FL

Position in EXEL

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$2,740,885

-$278,651 QoQ

Shares Held

63,905

-7.2% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 99.00477270949065.ToString("F0")% Shared 0.9952272905093498.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Moran Wealth Management, LLC holds $27,467,675 across 10 Biotechnology names. EXEL ranks #5 (10.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	175,822	$8,434,180
2	CPRX	Catalyst Pharmaceuticals, Inc.	168,961	$4,183,474
3	LGND	Ligand Pharmaceuticals Inc	19,306	$3,854,442
4	REGN	Regeneron Pharmaceuticals, Inc.	4,398	$3,398,070
5	EXEL	Exelixis, Inc. This page	63,905	$2,740,885
6	HALO	Halozyme Therapeutics, Inc.	30,477	$1,969,728
7	STOK	Stoke Therapeutics, Inc.	40,552	$1,320,373
8	CRSP	CRISPR Therapeutics AG	25,302	$1,203,616

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,740,885	63,905	-7.2%	Shares	Defined	2026-04-27
2025-12-31	$3,019,536	68,892	-4.1%	Shares	Sole	2026-01-26
2025-09-30	$2,966,042	71,817	-24.7%	Shares	Sole	2025-10-23
2025-06-30	$4,201,352	95,312	+2.2%	Shares	Sole	2025-07-28
2025-03-31	$3,443,602	93,272	+232.1%	Shares	Sole	2025-04-23
2024-12-31	$935,263	28,086	-6.2%	Shares	Sole	2025-02-07
2024-09-30	$777,098	29,946	+59.1%	Shares	Sole	2024-11-08
2024-06-30	$423,042	18,827	+58.8%	Shares	Sole	2024-08-13
2024-03-31	$281,390	11,858	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.